Amgen Czech Republic - Indebtedness

Net Debt/EBITDA & Net Debt/Equity
Pharmaceutical | Czech Republic | November 09, 2018
$2.99
Excel Sheet

Amgen Czech Republic's net debt reached CZK -0.283 mil and accounted for -0.147% of equity at the end of 2017. The ratio is down 17.4% when compared to the previous year.

Historically, the firm’s net debt to equity reached an all time high of 38.7% in 2015 and an all time low of -80.1% in 2005.

When compared to EBITDA, net debt amounted to -0.006x at the end of the year. The ratio reached an all time high of 1.53 in 2015 and an all time low of -2.63 in 2008.

You can see all the company’s data at Amgen Czech Republic Profile, or you can download a report on the company in the report section.

Net Debt/EBITDA Unit 2010 2011 2012 2013 2014 2015 2016 2017
Amgen Czech Republic ... ... -0.005 0.709 1.53
Bayer Czech Republic -0.298 -0.098 0.140 0.150 0.890
GlaxoSmithKline Czech Republic 0.438 1.02 1.69 -0.001 -3.71
Merck Czech Republic 1.87 1.39 2.80 0.353 -0.026
Novartis Czech Republic 3.22 0.696 -0.064 0.826 -0.015
Pfizer Czech Republic 2.16 -1.32 -0.141 -1.65 -0.037
Roche Czech Republic -0.002 0.737 0.867 2.04 3.15 ...
Sanofi-Aventis Czech Republic 12.8 16.5 8.87 27.7 4.27
Servier Czech Republic ... ... -1.54 -2.09 -1.74 -0.839
Walmark 0.471 4.81 4.37 2.26 -5.37
AVERAGE 2.70 2.30 2.22 1.64 3.06 -0.017 -1.20 2.64